Anupam Rasayan India: The Board of Directors of the Company at its meeting held on November 06, 2026, has considered and approved…
Anupam Rasayan India (ANURAS) filed a disclosure titled "The Board of Directors of the Company at its meeting held on November 06, 2026, has considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the…". The company is valued…
What happened
Anupam Rasayan India (ANURAS) filed a disclosure with the exchanges on 6 November 2026 at 03:35 PM titled "The Board of Directors of the Company at its meeting held on November 06, 2026, has considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the…".
Company snapshot
Anupam Rasayan India is a small-cap company in the Chemicals sector, with a market value of about ₹13,266 crore.
The stock last traded at ₹1,165.2, against a 52-week range of ₹1,053.6–₹1,415 (17.6% below the high).
Before this filing the shares had moved −1.6% over the month and −5.6% over three months. Average daily turnover over the last 20 sessions was about ₹44.31 crore.
Promoters held 59.07% at the end of Q1 FY27; 21.79% of promoter shares were pledged. Foreign institutions owned 7.71% and domestic institutions 0.38%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 486 | 34 | 3.1 |
| Q2 FY26 | 731 | 44.4 | 3.93 |
| Q3 FY26 | 512 | 49 | 4.31 |
| Q4 FY26 | 636 | 42.7 | 3.75 |
| Q1 FY27 | 655 | 38.6 | 3.39 |
What history shows
This is not the company's first results disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 0.9% on average the next trading day and was up 3.0% on average after five days (3 filings with price data).
Across 235 similar disclosures by other Chemicals companies, shares moved −1.2% on average the next day and −1.3% over five days; 38% of them rose the next day.
Market-wide, 10,840 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 14 Aug 2026 | Results | −0.9% | +3.0% |
| 14 Aug 2026 | Financial Results For The Quarter Ended June 30, 2026. | −0.9% | +3.0% |
| 14 Aug 2026 | Board Meeting Outcome for Outcome Of Board Meeting Held On August… | −0.9% | +3.0% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 6 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers
- Anupam Rasayan files draft offer for Bliss GVS
- Anupam Rasayan India Ltd (ANURAS.BO) Seasonal Returns Chart - Yahoo Finance
- Anupam Rasayan India (NSE:ANURAS): What Is the Q2 & H1 FY27 Earnings Call About?
- Anupam Rasayan Schedules Q2 and H1 FY27 Earnings Call
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.